PAFP Provider Feedback Trial in Nepal
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03071029|
Recruitment Status : Completed
First Posted : March 6, 2017
Last Update Posted : May 9, 2017
|Condition or disease||Intervention/treatment||Phase|
|Health Behavior||Behavioral: Monthly PAFP rates displayed at clinics.||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||12000 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Applying Behavioural Insights to Improve Take up of Post-abortion Family Planning: In-depth Study in Nepal|
|Study Start Date :||July 2016|
|Actual Primary Completion Date :||February 2017|
|Actual Study Completion Date :||February 2017|
Experimental: Intervention (receive data updates)
Intervention clinics will receive a monthly poster that centres will receive which informs service providers of the PAFP LARC uptake rate at their centre. This is a step-wedged randomised controlled trial where all the clinics will eventually receive an intervention by the end of the study.
Behavioral: Monthly PAFP rates displayed at clinics.
Providers will receive visual and text feedback on their centre's PAFP uptake rates as they compare to the uptake rates of other centres. The feedback will be delivered monthly in a physical paper format.
No Intervention: Control (no data updates)
Service providers at these clinics will not receive monthly information on PAFP LARC rates.
- Long term reversible contraceptives uptake as a percentage of post-abortion family planning uptake among safe abortion clients within 2 weeks [ Time Frame: 2 weeks post-abortion ]The study aims to observe a minimum 4% difference in PAFP LARC rates at two weeks post-abortion between intervention and control participants.
- Types of family planning method used after safe abortion procedure [ Time Frame: 2 weeks post abortion ]% of participants using different types of family planning methods at two weeks post-abortion, including % using short-acting vs long-acting contraceptives.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03071029
|Principal Investigator:||Saugato Datta||ideas42|
|Principal Investigator:||Karina Lorenzana||ideas42|
|Principal Investigator:||Pragya Gartoulla, PhD||Marie Stopes Nepal|